Alzheimer’s Research UK (ARUK) released their “Defeat Dementia: the evidence and a vision for action” last week to coincide with the Global Dementia Legacy Event and the launch of their “Defeat Dementia” campaign.
This report draws on analyses from Office of Health Economics (OHE) which model the potential impact of new treatments (as yet not developed) for dementia if these could be introduced in the UK by 2020. A therapy delaying the onset of dementia by five years could, hypothetically, reduce the number of cases by a third and alleviate economic costs by over £21 billion (36%) by 2050.
“Alzheimer’s Research UK and OHE’s analysis modelled the current and future socio-economic impacts of dementia in the UK, estimating prevalence and associated care costs up to 2050. The team then modelled the impact that disease modifying therapies might bring if introduced in 2020. Two scenarios were modelled: a therapy to delay disease onset, and an intervention that would slow disease progression”.
Defeat Dementia: the evidence and a vision for action. London: Alzheimer’s Research UK, June 2014.
[A version of this item features in Dementia: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 12, July 2014].
A 2018 pictorial feature:
Changing the lives of people with dementia. London: BBC Health News, September 21st 2018.